Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$2.61M Sell
142,579
-113,799
-44% -$2.01M 0.03% 488
2014
Q4
$2.41M Buy
256,378
+115,796
+82% +$1.92M 0.03% 506
2014
Q3
$1.88M Buy
140,582
+7,886
+6% +$115K 0.03% 474
2014
Q2
$1.93M Buy
132,696
+31,780
+31% +$464K 0.03% 496
2014
Q1
$1.59M Sell
100,916
-1,612
-2% -$25.7K 0.02% 515
2013
Q4
$1.69M Sell
102,528
-252
-0.2% -$3.69K 0.03% 493
2013
Q3
$1.31M Buy
102,780
+310
+0.3% +$3.68K 0.02% 519
2013
Q2
$1.18M Buy
+102,470
New +$1.15M 0.02% 526

Other funds holding GNTX

Baird's GNTX Position: Q1 2015 in Review

Baird reduced its Gentex (GNTX) stake by 44% in Q1 2015, selling an estimated $2.01M and leaving 142,579 shares worth $2.61M. The position accounts for 0.03% of the portfolio, ranked #488.

Baird first reported a position in GNTX in Q2 2013 and has held it in 8 quarters since. 347 funds tracked by Wall St. Rank hold GNTX as of Q1 2015.

  • Baird held 142,579 shares of Gentex worth $2.61M as of Q1 2015.
  • Baird sold 113,799 Gentex shares in Q1 2015, an estimated $2.01M.
  • Gentex made up 0.03% of Baird's portfolio in Q1 2015, its #488 holding.
  • Baird first reported a position in Gentex in Q2 2013 and has held it in 8 quarters since.
  • 347 funds tracked by Wall St. Rank held Gentex as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.